← Back to Search

Financial Incentives + Text Messaging for Type 2 Diabetes

N/A
Recruiting
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willingness to wear Fitbit during waking hours daily for duration of run-in and intervention
Diagnosis with prediabetes or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial aims to use financial incentives and text messaging to promote physical activity in obese adolescents and young adults with type 2 diabetes, who often have low levels of physical activity.

Who is the study for?
The BEAM trial is for overweight or obese adolescents and young adults aged 13 to 22 with prediabetes or type 2 diabetes. Participants must have a smartphone, agree to wear a Fitbit during the day, and not be very physically active already. Those with severe cognitive issues, eating disorders, disabilities affecting movement, who are pregnant, or don't speak English can't join.Check my eligibility
What is being tested?
BEAM is testing an mHealth program that motivates physical activity using financial rewards and text messages in young people with type 2 diabetes or prediabetes. The interventions involve various combinations of reminders and incentives designed following behavioral economics principles.See study design
What are the potential side effects?
Since this trial focuses on increasing physical activity through motivational texts and financial incentives rather than medication, side effects may include typical exercise-related discomforts such as muscle soreness but no drug-related side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to wear a Fitbit daily during waking hours for the study period.
Select...
I have been diagnosed with prediabetes or type 2 diabetes.
Select...
I am overweight or obese according to BMI standards for my age and sex.
Select...
I am overweight or obese according to BMI standards for my age and sex.
Select...
I have been diagnosed with prediabetes or type 2 diabetes.
Select...
I am between 13 and 22 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Moderate to Vigorous Physical Activity (MVPA)
Secondary outcome measures
Daily Step Count

Trial Design

16Treatment groups
Experimental Treatment
Group I: Condition 9Experimental Treatment1 Intervention
1FLD=One text per day, fixed goal, loss incentive, daily goal time period.
Group II: Condition 8Experimental Treatment1 Intervention
2RGW=Two texts per day, ramped goal, gain incentive, weekly goal time period.
Group III: Condition 7Experimental Treatment1 Intervention
2RGD=Two texts per day, ramped goal, gain incentive, daily goal time period.
Group IV: Condition 6Experimental Treatment1 Intervention
2RLW=Two texts per day, ramped goal, loss incentive, weekly goal time period.
Group V: Condition 5Experimental Treatment1 Intervention
2RLD=Two texts per day, ramped goal, loss incentive, daily goal time period.
Group VI: Condition 4Experimental Treatment1 Intervention
1RGW=One text per day, ramped goal, gain incentive, weekly goal time period.
Group VII: Condition 3Experimental Treatment1 Intervention
1RGD=One text per day, ramped goal, gain incentive, daily goal time period.
Group VIII: Condition 2Experimental Treatment1 Intervention
1RLW=One text per day, ramped goal, loss incentive, weekly goal time period.
Group IX: Condition 16Experimental Treatment1 Intervention
2FGW=Two texts per day, fixed goal, gain incentive, weekly goal time period.
Group X: Condition 15Experimental Treatment1 Intervention
2FGD=Two texts per day, fixed goal, gain incentive, daily goal time period.
Group XI: Condition 14Experimental Treatment1 Intervention
2FLW=Two texts per day, fixed goal, loss incentive, weekly goal time period.
Group XII: Condition 13Experimental Treatment1 Intervention
2FLD=Two texts per day, fixed goal, loss incentive, daily goal time period.
Group XIII: Condition 12Experimental Treatment1 Intervention
1FGW=One text per day, fixed goal, gain incentive, weekly goal time period.
Group XIV: Condition 11Experimental Treatment1 Intervention
1FGD=One text per day, fixed goal, gain incentive, daily goal time period.
Group XV: Condition 10Experimental Treatment1 Intervention
1FLW=One text per day, fixed goal, loss incentive, weekly goal time period.
Group XVI: Condition 1Experimental Treatment1 Intervention
1RLD=One text per day, ramped goal, loss incentive, daily goal time period.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,716 Previous Clinical Trials
16,346,379 Total Patients Enrolled
8 Trials studying Insulin Resistance
2,892 Patients Enrolled for Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,348 Previous Clinical Trials
4,314,657 Total Patients Enrolled
87 Trials studying Insulin Resistance
13,155 Patients Enrolled for Insulin Resistance

Media Library

2FGD Clinical Trial Eligibility Overview. Trial Name: NCT04874415 — N/A
Insulin Resistance Research Study Groups: Condition 1, Condition 8, Condition 13, Condition 14, Condition 6, Condition 2, Condition 3, Condition 5, Condition 15, Condition 4, Condition 9, Condition 7, Condition 16, Condition 12, Condition 10, Condition 11
Insulin Resistance Clinical Trial 2023: 2FGD Highlights & Side Effects. Trial Name: NCT04874415 — N/A
2FGD 2023 Treatment Timeline for Medical Study. Trial Name: NCT04874415 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who can potentially benefit from participating in this medical experiment?

"This research endeavour is seeking 75 participants between the ages of 13 and 22 with a diagnosis of type 2 diabetes. Crucially, those wishing to join must meet certain standards including: having prediabetes or type two DM, being overweight/obese (BMI >85th percentile for age/sex), providing consent if 18+ years old, parental permission if below 18 and assent from minors aged 13-17; as well as agreeing to wear a Fitbit daily during waking hours & possessing a smartphone."

Answered by AI

Is this investigation open to those who are senior citizens?

"This trial is seeking participants who are between the ages of 13 and 22."

Answered by AI

Are there vacancies for prospective participants in this clinical experiment?

"As of now, this clinical trial is still welcoming patients. The first advertisement was posted on November 16th 2021 and the most recent update occurred October 6th 2022 according to information hosted on clinicaltrials.gov"

Answered by AI

What is the currently estimated sample size for this research endeavor?

"Affirmative. Clinicaltrials.gov data supports the notion that this trial is actively recruiting participants, with 75 patients being sought from a single medical site since it was first posted on November 16th 2021 and updated lastly on October 6th 2022."

Answered by AI

Who else is applying?

What site did they apply to?
UPMC Children's Hospital of Pittsburgh
What portion of applicants met pre-screening criteria?
Did not meet criteria
~0 spots leftby Apr 2024